<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Protein-tyrosine phosphatase (<z:chebi fb="0" ids="52242">PTP</z:chebi>)1B is a negative regulator of insulin signaling and a therapeutic target for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we have assessed the role of PTP1B in the insulin sensitivity of skeletal muscle under physiological and insulin-resistant conditions </plain></SENT>
<SENT sid="2" pm="."><plain>Immortalized myocytes have been generated from PTP1B-deficient and <z:mp ids='MP_0002169'>wild-type</z:mp> neonatal mice </plain></SENT>
<SENT sid="3" pm="."><plain>PTP1B(-/-) myocytes showed enhanced insulin-dependent activation of insulin receptor autophosphorylation and downstream signaling (tyrosine phosphorylation of insulin receptor substrate [IRS]-1 and IRS-2, activation of phosphatidylinositol 3-kinase, and serine phosphorylation of AKT), compared with <z:mp ids='MP_0002169'>wild-type</z:mp> cells </plain></SENT>
<SENT sid="4" pm="."><plain>Accordingly, PTP1B(-/-) myocytes displayed higher insulin-dependent stimulation of <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake and GLUT4 translocation to the plasma membrane than <z:mp ids='MP_0002169'>wild-type</z:mp> cells </plain></SENT>
<SENT sid="5" pm="."><plain>Treatment with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha (TNF-alpha) induced <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> on <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake, impaired insulin signaling, and increased PTP1B activity in <z:mp ids='MP_0002169'>wild-type</z:mp> cells </plain></SENT>
<SENT sid="6" pm="."><plain>Conversely, the lack of PTP1B confers protection against <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> by TNF-alpha in myocyte cell lines and in adult male mice </plain></SENT>
<SENT sid="7" pm="."><plain><z:mp ids='MP_0002169'>Wild-type</z:mp> mice treated with TNF-alpha developed a pronounced <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> along the <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test, accompanied by an impaired insulin signaling and increased PTP1B activity in muscle </plain></SENT>
<SENT sid="8" pm="."><plain>However, mice lacking PTP1B maintained a rapid clearance of <z:chebi fb="105" ids="17234">glucose</z:chebi> and insulin sensitivity and displayed <z:mpath ids='MPATH_458'>normal</z:mpath> muscle insulin signaling regardless the presence of TNF-alpha </plain></SENT>
</text></document>